Pullan's Pieces - A Business Development View of the Oncology Landscape
With
an unprecedented number of new investigational agents and companies in
today’s oncology space, it can be challenging to track and understand
current oncology agents in clinical development, the clinical trials
testing them, and what it means for the future.
In this whitepaper, biopharma partnering expert and Life Sciences consultant, Linda Pullan, PhD, explores the current oncology landscape and offers an insightful perspective on trends, pipeline by indication, dealmaking, and the top ten oncology companies and the drugs they’re developing.
In Part I of the three-part series you'll learn
: